Predicting Pathological Complete Response in Rectal Cancer Using Machine Learning

Clinical trial NCT07509632 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07509632
Sponsor: Peking University People's Hospital
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Rectal Cancers Pathological Complete Response Neoadjuvant Chemoradiotherapy Machine Learning

Start date: 2026-02-04
Primary completion: 2026-04-25
Enrollment: 320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.